| 000 | 01858 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515074212.0 | ||
| 264 | 0 | _c20071120 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/j.canlet.2007.06.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYde, Christina Westmose | |
| 245 | 0 | 0 |
_aInduction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT. _h[electronic resource] |
| 260 |
_bCancer letters _cOct 2007 |
||
| 300 |
_a229-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCasein Kinase II _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Receptor Modulators _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPolyunsaturated Alkamides _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aTamoxifen _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aFrogne, Thomas | |
| 700 | 1 | _aLykkesfeldt, Anne E | |
| 700 | 1 | _aFichtner, Iduna | |
| 700 | 1 | _aIssinger, Olaf-Georg | |
| 700 | 1 | _aStenvang, Jan | |
| 773 | 0 |
_tCancer letters _gvol. 256 _gno. 2 _gp. 229-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2007.06.010 _zAvailable from publisher's website |
| 999 |
_c17164552 _d17164552 |
||